1. Alexander J, Bryson K. T helper (h)1/Th2 and
Leishmania: paradox rather than paradigm. Immunol Lett. 2005. 99:17-23. PMID:
15894106.
2. Andrade ZA, Reed SG, Roters SB, Sadigursky M. Immunopathology of experimental cutaneous leishmaniasis. Am J Pathol. 1984. 114:137-148. PMID:
6691411.
3. Barral-Netto M, Cheever AW, Lawley TJ, Ottesen EA. Cell-mediated and humoral immune responses in capuchin monkeys infected with
Schistosoma japonicum or
Schistosoma mansoni. Am J Trop Med Hyg. 1983. 32:1335-1343. PMID:
6196978.
4. Barral-Netto M, de Freitas LAR, Andrade ZA. Histopathologic changes induced by vaccination in experimental cutaneous leishmaniasis of BALB/c mice. Am J Pathol. 1987. 127:271-278. PMID:
3495185.
5. Barral-Netto M, von Sohsten RL, Teixeira M, dos Santos WLC, Pompeu ML, Moreira RA, Oliveira JT, Cavada BS, Falcoff E, Barral A. In vivo protective effect of the lectin from
Canavalia brasiliensis on BALB/c mice infected by
Leishmania amazonensis. Acta Trop. 1996. 60:237-250. PMID:
8659323.
6. Cardoso SR, da Silva JCF, da Costa RT, Mayrink W, Melo MN, Michalick MSV, Liu IAW, Fujiwara RT, Nascimento E. Identification and purification of immunogenic proteins from nonliving promastigote polyvalent
Leishmania vaccine (Leishvacin). Rev Soc Bras Med Trop. 2003. 36:193-199. PMID:
12806454.
7. Deplazes P, Smith NC, Arnold P, Lutz H, Eckert J. Specific IgG1 and IgG2 antibody responses of dogs to
Leishmania infantum and other parasites. Parasite Immunol. 1995. 17:451-458. PMID:
8552413.
8. Elvin-Lewis M. Should we be concerned about herbal remedies? J Ethnopharmacol. 2001. 75:141-164. PMID:
11297844.
9. Guimarães ET, Santos LA, dos Santos RR, Teixeira MM, dos Santos WLC, Soares MBP. Role of inertelukin-4 prostaglandin E2 in
Leishmania amazonensis infection of BALB/c. Microbes Infect. 2006. 8:1219-1226. PMID:
16531090.
10. Hernández MXS, Barçante TA, Vilela L, Tafuri WL, Afonso LCC, Vieira LQ. Vaccine-induced protection against
Leishmania amazonensis is obtained in the absence of IL-12/23p40. Immunol Lett. 2006. 105:38-47. PMID:
16466810.
11. Ivory C, Chadee K. DNA vaccines: designing strategies against parasitic infections. Genet Vaccines Ther. 2004. 2:17. PMID:
15579202.
12. Kaye PM, Curry AJ, Blackwell JM. Differential production of Th1 and Th2 derived cytokines does not determine the genetically controlled or vaccine induced rate of cure in murine leishmaniasis. J Immunol. 1991. 146:2763-2770. PMID:
1901883.
13. Liew FY, O'Donnell CA. Immunology of leishmaniasis. Adv Parasitol. 1993. 32:161-259. PMID:
8237615.
14. Liew FY, Hale C, Howard JG. Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal
Leishmania major infection. J Immunol. 1985. 135:2095-2101. PMID:
4020140.
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951. 193:265-275. PMID:
14907713.
16. Machado-Pinto J, Pinto J, da Costa CA, Genaro O, Marques MJ, Modabber F, Mayrink W. Immunochemotherapy for cutaneous leishmaniasis: a controlled trial using killed
Leishmania (
Leishmania)
amazonensis vaccine plus antimonials. Int J Dermatol. 2002. 41:73-78. PMID:
11982640.
17. Marques-da-Silva EA, Coelho EAF, Gomes DCO, Vilela MC, Masioli CZ, Tavares CAP, Fernandes AP, Afonso LCC, Rezende SA. Intramuscular immunization with p36(LACK) DNA vaccine induces IFN-γ production but does not protect BALB/c mice against
Leishmania chagasi intravenous challenge. Parasitol Res. 2005. 98:67-74. PMID:
16261353.
18. Mohammadi MR, Zeinali M, Ardestani SK, Kariminia A. Identification of novel
Leishmania major antigens that elicit IgG2a response in resistant and susceptible mice. Korean J Parasitol. 2006. 44:43-48. PMID:
16514281.
19. Moingeon P, Haensler J, Lindberg A. Towards the rational design of Th1 adjuvants. Vaccine. 2001. 19:4363-4372. PMID:
11483260.
20. Oliveira-Freitas E, Casas CP, Borja-Cabrera GP, Santos FN, Nico D, Souza LOP, Tinoco LW, da Silva BP, Palatnik M, Parente JP, Palatnik-de-Sousa CB. Acylated and deacylated saponins of
Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis. Vaccine. 2006. 24:3909-3920. PMID:
16556475.
21. Palatnik de Sousa CB, Santos WR, Casas CP, Paraguai de Souza E, Tinoco LW, da Silva BP, Palatnik M, Parente JP. Protective vaccination against murine visceral leishmaniasis using aldehyde-containing
Quillaja saponaria sapogenins. Vaccine. 2004. 22:2470-2479. PMID:
15193411.
22. Panunto-Castelo A, Souza MA, Roque-Barreira MC, Silva JS. KM
+, a lectin from
Artocarpus integrifolia, induces IL-12p40 production by macrophages and switches from type 2 to type 1 cell mediated immunity against
L. major antigens, resulting in BALB/c mice resistance to infection. Glycobiology. 2001. 11:1035-1042. PMID:
11805076.
23. Peumans WJ, van Damme EJ. The role of lectins in plant defense. Histochem J. 1995. 27:253-271. PMID:
7635758.
24. Rogerio AP, Cardoso CR, Fontanari C, Souza MA, Afonso-Cardoso SR, Silva EVG, Koyama NS, Basei FL, Soares EG, Calixto JB, Stowell SR, Dias-Baruffi M, Faccioli LH. Anti-asthmatic potential of a D-galactose-binding lectin from
Synadenium carinatum latex. Glycobiology. 2007. 17:795-804. PMID:
17522108.
25. Scott P, Natovitz P, Coffman RL, Pearce E, Sher A. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med. 1988. 168:1675-1684. PMID:
2903212.
26. Scott P, Pearce E, Natovitz P, Sher A. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. J Immunol. 1987. 139:221-227. PMID:
3495599.
27. Souza MA, Afonso-Cardoso SR, Machado AP, Borges FAC, Lanza H, Pena JD. The adjuvant effect of saponin (Quilara bark) in the vaccine against murine cutaneous leishmaniasis. Biosc J. 2004. 20:109-116.
28. Souza MA, Amâncio-Pereira F, Barros-Cardoso CR, Gomes-Silva A, Silva EG, Andrade LR, Pena JD, Lanza H, Afonso-Cardoso SR. Isolation and partial characterization of a D-galactose-binding lectin from the látex of Synadenium carinatum. Braz Arch Biol Technol. 2005. 48:705-716.
29. Späth GF, Lye LF, Segawa H, Turco SJ, Beverley SM. Identification of a compensatory mutant (
lpg2_REV) of
Leishmania major able to survive as amastigotes within macrophages without
LPG2-dependent glycoconjugates and its significance to virulence and immunization strategies. Infect Immun. 2004. 72:3622-3627. PMID:
15155672.
30. Stavnezer J. Immunoglobulin class switching. Curr Opin Immunol. 1996. 8:199-205. PMID:
8725943.
31. Teixeira CR, Cavassani KA, Gomes RB, Teixeira NJ, Roque-Barreira MC, Cavada BS, da Silva JS, Barral A, Barral-Netto M. Potential of KM+ lectin in immunization against
Leishmania amazonensis infection. Vaccine. 2006. 24:3001-3008. PMID:
16455170.
32. World Health Organization Report. Advances in battle against leishmaniasis. Tropical Disease Research News. 1998. no. 57.